Effect of retinoid pretreatment on outcomes of patients treated by photodynamic therapy for actinic keratosis of the hand and forearm

Journal of Drugs in Dermatology

Volumn 10, Issue 10, 2011, Pages 1124-1132

  Galitzer, Barry I ^a  

^a Dermatologic Laser and Surgery Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; KERASTICK; TAZAROTENE; UNCLASSIFIED DRUG;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; BLUE LIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRY SKIN; ERYTHEMA; FEMALE; GEL; HAND DISEASE; HUMAN; IRRADIATION; MALE; PHOTODYNAMIC THERAPY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN BURNING SENSATION; SKIN EDEMA; SKIN PIGMENTATION; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; DERMATOLOGIC AGENTS; ERYTHEMA; FEMALE; FOREARM; GELS; HAND DERMATOSES; HUMANS; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; NICOTINIC ACIDS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 80054762068     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Gupta AK, Cooper EA, Feldman SR, Fleischer AB Jr. A survey of office visits for actinic keratosis as reported by NAMCS, 1990-1999. National Ambulatory Medical Care Survey. Cutis. 2002;70(2 Suppl);8-13.
2. Kalisiak MS, Rao J. Photodynamic therapy for actinic keratoses. Dermatol Clin. 2007;25(1);15-23. (Pubitemid 44780060)
3. Nestor MS, Gold MH, Kauvar AN, et al. The use of photodynamic therapy in dermatology;results of a consensus conference. J Drugs Dermatol. 2006;5(2);140-154.
4. Han A, Penrose C, Goldsmith A, Marmur ES. Case-based considerations in the treatment of actinic keratoses;utilizing combination or sequential therapy with 5-fluorouracil cream and destructive treatments. J Drugs Dermatol. 2010;9(7);864-869.
5. Tutrone WD, Saini R, Caglar S, et al. Topical therapy for actinic keratoses, II;Diclofenac, colchicine, and retinoids. Cutis. 2003;71(5);373-379.
6. Kligman AM, Grove GL, Hirose R, Leyden JJ. Topical tretinoin for photoaged skin. J Am Acad Dermatol. 1986;15(4 Pt 2);836-859. (Pubitemid 17170790)
7. Weinstein GD, Nigra TP, Pochi PE, et al. Topical tretinoin for treatment of photodamaged skin. A multicenter study. Arch Dermatol. 1991;127(5);659-665.
8. Bollag W, Ott F. Vitamin A acid in benign and malignant epithelial tumours of the skin. Acta Derm Venereol Suppl (Stockh). 1975;27-29;74;163-166.
9. Kligman AL, Thorne EG. Topical therapy of actinic keratoses with tretinoin. In: Marks R, ed. Retinoids in Cutaneous Malignancy. Oxford, UK: Blackwell Scientific Publications. 1991; 66-73.
10. Thorne EG. Long-term clinical experience with a topical retinoid. Br J Dermatol. 1993;127(Suppl);31-36.
11. Alirezai M, Dupuy P, Amblard P, et al. Clinical evaluation of topical isotretinoin in the treatment of actinic keratoses. J Am Acad Dermatol. 1994;30(3);447-451. (Pubitemid 24129437)
12. Kang S, Leyden JJ, Lowe NJ, et al. Tazarotene cream for the treatment of facial photodamage;a multi center, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks. Arch Dermatol. 2001;137(12);1597-1604. (Pubitemid 34000908)
13. Phillips TJ, Gottlieb AB, Leyden JJ, et al. Tazarotene Cream Photo-damage Clinical Study Group. Efficacy of 0.1% tazarotene cream for the treatment of photodamage;a 12-month multicenter, randomized trial. Arch Dermatol. 2002;138(11);1486-1493. (Pubitemid 35315739)
14. Silapunt S, Goldberg LH, Alam M. Topical and light-based treatments for actinic keratoses. Semin Cutan Med Surg. 2003;22(3);162-170. (Pubitemid 37392719)
15. Bercovitch L. Topical chemotherapy of actinic keratoses of the upper extremity with tretinoin and 5-fluorouracil;a double-blind controlled study. Br J Dermatol. 1987;116(4);549-552. (Pubitemid 17036882)
16. Noble S, Wagstaff AJ. Tretinoin. A review of its pharmacological properties and clinical efficacy in the topical treatment of photo-damaged skin. Drugs Aging. 1995;6(6);479-496.
17. Sherertz EF, McTiernan RG. Topical tretinoin enhances percutaneous absorption of 5-fluorouracil in vitro. J Am Acad Dermatol. 1987;17(4);692-694. (Pubitemid 17147816)
18. Odom R. Managing actinic keratoses with retinoids. J Am Acad Dermatol. 1998;39;S74-S78. (Pubitemid 28367291)
19. Sander CA, Pfeiffer C, Kligman AM, Plewig G. Chemotherapy for disseminated actinic keratoses with 5-fluorouracil and isotretinoin. J Am Acad Dermatol. 1997;36(2 Pt 1);236-238. (Pubitemid 27078918)
20. Sefton J, Kligman AM, Kopper SC, et al. Photodamage pilot study;a double-blind, vehicle-controlled study to assess the efficacy and safety of tazarotene 0.1% gel. J Am Acad Dermatol. 2000;43(4);656-663.
21. Kaidbey KH, Kligman AM, Yoshida H. Effects of intensive application of retinoic acid on human skin. Br J Dermatol. 1975;92(6);693-701.
22. Gilbert DJ. Treatment of actinic keratoses with sequential combination of 5-fluorouracil and photodynamic therapy. J Drugs Dermatol. 2005;4(2);161-163.
23. Shaffelburg M. Treatment of actinic keratoses with sequential use of photodynamic therapy; and imiquimod 5% cream. J Drugs Dermatol. 2009;8(1):35-39.
24. Szeimies RM, Karrer S, Sauerwald A, Landthaler M. Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses;an initial clinical study. Dermatology. 1996;192(3);246-251. (Pubitemid 26139209)
25. Jeffes EW, McCullough JL, Weinstein GD, et al. Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study. Arch Dermatol. 1997;133(6);727-732. (Pubitemid 27263706)
26. Sotiriou E, Apalla Z, Maliamani F, et al. Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities. J Eur Acad Dermatol Venereol. 2009;23(9);1061-1065.
27. Peck GL. Topical tretinoin in actinic keratosis and basal cell carcinoma. J Am Acad Dermatol. 1986;15(4 Pt 2);829-835. (Pubitemid 17170789)
28. Kligman AM, Thorne EG. Topical therapy of actinic keratoses with tretinoin. In: Saurat J-H, ed. Retinoids;10 years on. Basel: Karger. 1991;66-73.
29. Weinstock MA, Bingham SF, Cole GW, et al. Reliability of counting actinic keratoses before and after brief consensus discussion;the VA topical tretinoin chemoprevention (VATTC) trial. Arch Dermatol. 2001;137(8);1055-1058. (Pubitemid 32756463)
30. Altman DG. How large a sample? In: Gore SM, Altman DG, eds. Statistics in Practice. London: British Medical Association; 1982: 6-8.